U.S. market Closed. Opens in 5 hours 55 minutes

BJDX | Bluejay Diagnostics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/A249.04KN/AN/AN/A
Cost of Revenue780.96K200.13K145.72K157.04K142.97K
Gross Profit-780.96K48.91K-145.72K-157.04K-142.97K
Operating Expenses9.53M9.37M3.16M1.20M1.63M
Selling, General & Admin3.82M5.21M2.08M669.14K1.18M
Research & Development5.71M4.15M1.15M527.25K454.61K
Other Operating Expenses0258.14K-75.00K5.54K749.45K
Operating Income-10.31M-9.32M-3.23M-1.20M-1.63M
Other Expenses / Income357.33K20.83K-258.13K38.11K811.57K
Before Tax Income-9.95M-9.30M-3.49M-1.16M-819.84K
Income Tax Expenses5.00-69.06K241.39K-32.57K-62.13K
Net Income-9.95M-9.23M-3.73M-1.13M-757.72K
Interest ExpensesN/A-20.83K367.46K27.00KN/A
Basic Shares Outstanding137.06K126.03K53.27K19.67K19.67K
Diluted Shares Outstanding137.06K126.03K53.27K19.67K19.67K
EBITDA-9.53M-9.06M-3.14M-1.10M-1.50M
EBITDA Margin0.00%-3,637.82%0.00%0.00%0.00%
EBIT-9.95M-9.32M-3.12M-1.13M-819.84K
EBIT Margin0.00%-3,741.48%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙